On Perception and Consciousness in HPPD: A Systematic Review
This review (2021; n=97) finds that hallucinogen-persisting perception disorder (HPPD) encompasses more characteristics than currently recognized by the DSM-5. The most common (of the 64 unique) symptoms were 76% Alice in Wonderland syndrome (AIWS) characteristics (distorted perception and disorientation), 50% non-visual symptoms, and 38% perceptual symptoms not liked to earlier states under the influence.
Authors
- Ermentrout, G. B.
- Vis, P. J.
- Goudriaan, A. E.
Published
Abstract
Hallucinogen-persisting perception disorder (HPPD) features as a diagnostic category in the DSM-5, ICD-11, and other major classifications, but our knowledge of the phenomenology of the perceptual symptoms involved and the changes in consciousness during the characteristic flashbacks is limited. We systematically evaluated original case reports and case series on HPPD to define its phenomenology, associated (psycho)pathology, and course. Our search of PubMed and Embase yielded 66 relevant publications that described 97 people who, together, experienced 64 unique symptoms of HPPD. Of these, 76% concerned symptoms characteristic of Alice in Wonderland syndrome, over 50% non-visual symptoms, and 38% perceptual symptoms not clearly linked to prior intoxication states. This is in contrast with the DSM-5 diagnostic criteria for HPPD. Even though less than half of the patients showed a protracted disease course of over a year, a third achieved remission. However, in patients with co-occurring depression (with or without anxiety) HPPD symptoms persisted longer and treatment outcomes were more often negative. Thus, unlike the acute stages of psychedelic drug intoxication, which may be accompanied by altered states of consciousness, HPPD is rather characterized by changes in the content of consciousness and an attentional shift from exogenous to endogenous phenomena. Since HPPD is a more encompassing nosological entity than suggested in the DSM-5, we recommend expanding its diagnostic criteria. In addition, we make recommendations for clinical practice and future research.
Research Summary of 'On Perception and Consciousness in HPPD: A Systematic Review'
Introduction
The psychedelic literature routinely characterises these substances as inducing 'altered states of consciousness', yet the nature of the alteration — whether in the level or the content of consciousness — is rarely examined precisely. This distinction becomes particularly important in hallucinogen-persisting perception disorder (HPPD), a condition in which perceptual disturbances arise and persist long after the acute drug effects have resolved. Whether HPPD represents an alteration in the level of consciousness, a narrowed or heightened state, or instead a selective disruption in the content of conscious perception — without changes to awareness or arousal per se — has not been systematically investigated. This systematic review aimed to characterise the phenomenology of HPPD based on published case reports, to determine which perceptual phenomena are most commonly reported, to map their relationship to known syndromes and to theories of conscious perception, and to assess pathophysiology, classification, and treatment evidence.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Topics
- APA Citation
Vis, P. J., Goudriaan, A. E., ter Meulen, B. C., & Blom, J. D. (2021). On Perception and Consciousness in HPPD: A Systematic Review. Frontiers in Neuroscience, 15. https://doi.org/10.3389/fnins.2021.675768
References (6)
Papers cited by this study that are also in Blossom
Bayne, T., Carter, O. · Neuroscience of Consciousness (2018)
Halpern, J. H., Pope Jr, H. G. · Drug and Alcohol Dependence (2003)
Lerner, A. G. · The Israel Journal of Psychiatry and Related Sciences; Jerusalem (2015)
Lerner, A. G. · The Israel Journal of Psychiatry and Related Sciences; Jerusalem (2014)
Litjens, R. P. W., Brunt, T. M., Alderliefste, G. et al. · European Neuropsychopharmacology (2014)
Martinotti, G., Santacroce, R., Pettorruso, M. et al. · Brain Sciences (2018)
Cited By (5)
Papers in Blossom that reference this study
Sulstarova, A., Scheuerlein, L., Monari, S. et al. · Asian Journal of Psychiatry (2025)
Dourron, H. M., Nichols, C. D., Simonsson, O. et al. · Psychopharmacology (2023)
Nikolič, M., Viktorin, V., Zach, P. et al. · European Neuropsychopharmacology (2023)
Prugger, J., Hirschfeld, T., Majic, T. et al. · Neuropsychopharmacology (2023)
Bouso, J. C., Andión, O., Sarris, J. et al. · PLOS Global Public Health (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.